AI assistant
Microbot Medical Inc. — Director's Dealing 2014
Jun 26, 2014
33819_dirs_2014-06-26_1be4ae1c-2f88-4e68-910b-171171f30e5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2014-06-06
Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-06 | Common Stock | F | 35245 | $1.42 | Disposed | 377506 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3643 | Indirect |
| Common Stock | 21642 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by her from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 210,000 restricted stock units, with 70,000 vesting on each of June 6, 2015, June 6, 2016, and June 6, 2017; and (2) 43,333 restricted stock units vesting on January 27, 2015.
F3: 3,643 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.
F4: Shares held in 401(k) account in accordance with issuer's employer-match policies.